PHARMA NEWS, MULT...
Follow
Find
31.6K views | +5 today

5 Reasons Pharma Should Reconsider Instagram

From www.intouchsol.com

More and more, Instagram is becoming a viable social channel for pharma, if used in the right way. So here are five reasons we believe pharmas should take a new look at Instagram.

No comment yet.

Study shows women view health differently than industry thinks they do

From www.mmm-online.com

A deep dive by the think tank Center for Talent Innovation indicates pharma and payers need to widen their definition of health when communicating with women.
No comment yet.

Tech it out: Pfizer, AARP and UnitedHealthcare push innovation

From www.fiercepharmamarketing.com

The venture, called Project Catalyst, is focusing on technology for people over age 50--not surprisingly, given AARP's involvement. Direct connections with patients--and continual feedback from them--are also key to the project.

No comment yet.

Pharma companies turn to social media to improve corporate reputations

From www.prweek.com

The report, which is based on data from 14 pharma companies taken over a three-month peroid, found the average number of tweets by has gone up by 530 per cent since 2013 while Twitter followers have increased by nearly 300 per cent. 

The study, 'Connecting the dots: Which Pharma Companies are Succeeding in the Social Media Space?', also showed that companies that keep their social networks fresh with regular updates have the highest interaction from the community and their followers.

Boehringer Ingelheim, Bayer, Novartis and Merck, stood out as as the best performing companies in terms of being active on their social network profiles and encouraging large numbers of users to engage with them.

Rebecca Canvin, social media manager at Ogilvy Healthworld, said: "We know that some pharma companies have been cautious in their approach to social media, but our report clearly demonstrates a dramatic and successful increase in activity. Social media has changed the way pharma companies communicate – it allows them to build corporate reputation and engage in genuine, meaningful conversations with audiences. For companies who want to stand out from the crowd it’s time to be brave, get personal, educate and integrate social media into their wider marketing strategy."

The report recommends that pharma companies should be prepared to have honest conversations about their brands by developing strategies and identifying potential scenarios where they can respond as quickly as possible to their followers. 

The report also suggests that companies should aim to have a clear set of engagement guidelines to help manage difficult questions.


No comment yet.

Pharma's getting savvier about social, with Boehringer, Bayer leading the pack

From www.fiercepharmamarketing.com

Bigger isn't necessarily better when it comes to social media. But bigger is certainly better than drugmakers were doing a couple of years ago. Some companies are actually getting it right now, Ogilvy Healthworld says.

A small group of drugmakers are "connecting the dots," according to Ogilvy's latest audit of pharma's social media efforts. They're getting patients, doctors and the media interested, delivering relevant info, inspiring actual conversations.

A very small group, actually. Just 5 companies out of 14 that Ogilvy investigated. We'll get to those later. First, let's consider the fact that pharma's social media presence has grown--a lot. Drugmakers have 1.3 million Facebook followers, Ogilvy says. The average number of pharma tweets per week has gone up by 530% since 2013. The number of Twitter followers has tripled, to 790,000. Four companies even have Vine accounts.

"We know that some pharma companies have been cautious in their approach to social media, but our report clearly demonstrates a dramatic and successful increase in activity," Rebecca Canvin, social media manager at Ogilvy Healthworld, said in a release.

Some have been more successful than others, of course. To go from size to success, Ogilvy looked at more stats--how many followers, how frequent the updates, how many social accounts, how often posts or tweets were shared. The auditors also gauged interest--how much did followers care about a company's social chatter?

Which company came out on top won't be a surprise to those who keep an eye on such things: Boehringer Ingelheim, already a leading presence in 2013, took that lead much further. The German drugmaker's score almost doubled that of its closest rival, Bayer. And Bayer, in turn, bested third-place Novartis ($NVS) by an easy margin.

The remaining two companies "connecting the dots" were Merck ($MRK) and Johnson & Johnson ($JNJ), both of which made big leaps from 2013. In fact, all of the top 5 multiplied their social presences significantly.

Four other drugmakers have made some strides and some connections since Ogilvy's last audit. The rest are still doing the social thing at a beginner level--broadcasting content without engaging much at all, the audit showed.

It's a good thing for them that Ogilvy analyzed their successful peers to come up with some tips for improvement. "[I]t's time to be brave, get personal, educate and integrate social media into their wider marketing strategy," Canvin said.

But why? As the current experts at Boehringer told Ogilvy, the conversation is already out there. "People are talking about you, whether you're active or not," said Patricia Alves, Boehringer's social media and community manager. "Social media gives you the opportunity to engage in that conversation, to give your position and your statement, and maybe then hopefully change the opinion of one person or two."

- check out the Ogilvy Healthworld statement

No comment yet.

The five things we must tell our boss and colleagues

From boagworld.com

If an important part of our job is to increase awareness and understanding of digital across our organisation, what lessons do we need to teach?
No comment yet.

LE MARCHE PHARMACEUTIQUE EN FRANCE 2014 #laDATAréférence #hcsmeufr #infographie

No comment yet.

RETROUVEZ NOS ACTUALITES SUR LE SITE DU GIE GERS

From www.gie-gers.fr

Click here to edit the title

GIE_GERS's curator insight, April 29, 4:02 PM

Le GIE GERS est un groupement d’intérêt économique créé par les entreprises de l’Industrie Pharmaceutique. Depuis 40 ans, le GERS accompagne ses adhérents dans l’analyse des marchés et le pilotage de la performance et propose une donnée exhaustive unique en mutualisant les données du médicament et des produits de santé.

MSD lance DiabetoPartner sur l'Apple Watch

From buzz-esante.com

MSD France lance la première application Apple Watch dédiée aux diabétiques, pour améliorer le suivi quotidien de leur maladie, en partenariat avec la Fédération Française des Diabétiques : DiabetoPartner. 

No comment yet.

LE MARCHE PHARMACEUTIQUE EN FRANCE 2014 #laDATAréférence #hcsmeufr #infographie

No comment yet.

Comment réussir sa transformation digitale

From www.oxygrey.com

Découvrez les 3 étapes à suivre pour assurer votre transformation digitale dès aujourd'hui et définissez le prochain cap de croissance de votre entreprise.
No comment yet.

Digital disruption of medical education

From www.pharmaphorum.com

Len Starnes reflects on how digital trends are changing medical education in Europe and, in particular, medical society congresses. Online learning may be the direction of travel for medical education but it is by no means a straight road. Two...
No comment yet.

Roche Diabetes Care lance la page Facebook "Bien vivre mon diabète"

From buzz-esante.com

Le laboratoire Roche Diabetes Care enrichi son offre digitale pour accompagner le patient diabétique dans sa vie au quotidien avec le lancement d'une page Facebook : Bien vivre mon diabète. Découve...
No comment yet.

Will twitter Direct message new feature influence the way Pharma is using this channel ?

From www.fiercecmo.com

Twitter announced a feature that enables users to receive any private message—even from people they don't follow. Previously, users would only get direct messages from users that followed them.
No comment yet.

The State Of Digital Excellence In The Pharmaceutical Industry In 2015 Capabilities

From www.dt-associates.com

Pharmaceutical firms must adopt and consistently execute practices that lead to digital excellence and give them a competitive edge. Which of these firms are accelerating away from the rest of the marketplace? We found that only two—Merck and Bristol-Myers Squibb—are doing reasonably well and achieving excellence and maturity in their digital capability. Firms taking a disciplined approach to digital transformation achieved higher maturity in digital capability than their less-disciplined peers. To reach the next level of maturity, firms should invest in foundational digital capabilities, develop locally relevant plans, and bridge the gaps between marketing, digital, and IT.
No comment yet.

» « Bien vivre mon diabète » : Roche Diabetes Care France lance sa page Facebook

From www.mypharma-editions.com

Roche Diabetes Care France vient d'ouvrir la page Facebook « Bien vivre mon diabète ». Ce nouvel espace d’informations et d’échanges a pour objectif de faciliter le quotidien des patients diabétiques et d’améliorer leur qualité de vie, leur autonomie, leur confort et leur mobilité.
No comment yet.

Santé connectée: « Sanofi est à l'avant-garde de cette révolution »

From www.latribune.fr

Gilles Litman explique pour La Tribune comment le premier groupe pharmaceutique français veut développer une véritable stratégie e-santé pour compléter son offre médicamenteuse et auréoler son image d'une forte composante 2.0.
No comment yet.

Big Data et pharmacie : Roche s'inocule de nouvelles données

From www.silicon.fr

En plus des essais cliniques, les laboratoires Roche vont manipuler des données retraçant les effets de ses molécules sur la durée.
No comment yet.

Transformation digitale de l'industrie : une opportunité à 1 250 milliards d'euros | L'Atelier : Accelerating Business

From www.atelier.net

Roland Berger estime que si le secteur industriel européen rate son tournant numérique, il engrangerait une perte de plus de 605 milliards d'euros d'ici 2025.
No comment yet.

Which #Pharma Companies are BIG in Social Media Engagement? Hint: Doesn't Correlate with Sales!

From www.slideshare.net

Ogilvy CommonHealth Worldwide evaluated  how  14 major pharma companies  were  performing  across  six  key  categories:  


  1. Social presence: How  many  social  networks  was  the  company  on?   
  2. Activity: Was  the  content  kept  fresh  with  regular  updates?
  3. Engagement: Were  the  companies    engaging  their  users  and  generating interest?    
  4. Social network: How  simple  and  intuitive  was  the   connection  between  social  networks?    
  5. Virality: Was  the  content  spread  around   the  social  sphere?
  6. Sommunity Size: How  big  was  the  community?
No comment yet.

Stop, Collaborate and Listen: The Social Lives of Healthcare Professi…

From www.slideshare.net

Shwen Gwee's keynote presentation from the BDI "Future of Healthcare Professionals Collaboration Leadership Luncheon" hosted by Within3
No comment yet.

The Dilemma of the Tablet-Enabled Physician | Physicians Practice

From www.physicianspractice.com

"I value my time off. Years ago when first going onto EHR, I could not connect from my house so I learned to get everything done before leaving the office. My time off was truly unconnected. This EHR change to mobile is going to necessitate another change in work flow for me.

There are two ways to approach this subject:

1. It will allow me to follow my patients more closely since I can get their lab results and follow-up data without being in the office. This will improve my relationship with my patients and result in more detailed care for them.

2. I will never really be out of the office. This could have legal ramifications.

The answer will likely be having a better buddy system and sign-out criteria in our practice. Right now, I have a buddy that will keep an eye on my charts and labs when I am away. We try to notify our buddies when they need to take over. Sometimes, it doesn't always work that way. So far, nothing serious has gotten missed … but we must remain vigilant in making sure follow up happens."

No comment yet.

Why Pharma companies have no substantial impact on the mHealth app economy #pharma #hcsmeu

From research2guidance.com

Leading Pharma companies fail, to have a significant impact on the mHealth app market. More than 100 available apps have generated only limited reach.
No comment yet.

L'industrie pharmaceutique parie sur une médecine de plus en plus personnalisée #hcsmeufr

From www.ladepeche.fr

(AFP) - La médecine personnalisée, qui vise à proposer des traitements adaptés à chaque patient, continue à se développer contre le cancer, mais concerne désormais aussi des maladies chroniques comme le diabète, et pourrait même trouver des ...
No comment yet.